Immune milestones to predict CMV after letermovir

Blood Adv. 2024 Jun 11;8(11):2964-2966. doi: 10.1182/bloodadvances.2024012849.

J S Little^{1

2

3}, S Prockop^{4

5}

¹ Department of Medicine, Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA.
² Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, MA.
³ Department of Medicine, Harvard Medical School, Boston, MA.
⁴ Department of Pediatrics, Harvard Medical School, Boston, MA.
⁵ Hematopoietic Stem Cell Transplant Program, Dana-Farber Cancer Institute/Boston Children's Hospital Cancer and Blood Disorders Center, Boston, MA.

No abstract available

Publication types